메뉴 건너뛰기




Volumn 14, Issue 2, 2012, Pages 262-281

Applications of human pharmacokinetic prediction in first-in-human dose estimation

Author keywords

Allometric scaling; FIH dose; In vitro in vivo correlations; Pharmacokinetics; Prediction

Indexed keywords

TGN 1412;

EID: 84862777286     PISSN: 15507416     EISSN: None     Source Type: Journal    
DOI: 10.1208/s12248-012-9332-y     Document Type: Review
Times cited : (100)

References (99)
  • 1
    • 8844236997 scopus 로고    scopus 로고
    • Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose
    • DOI 10.1016/j.yrtph.2004.08.004, PII S0273230004001138
    • Contrera JF, Matthews EJ, Kruhlak NL, Benz RD. Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. Regul Toxicol Pharmacol. 2004;40 (3):185-206. (Pubitemid 39531301)
    • (2004) Regulatory Toxicology and Pharmacology , vol.40 , Issue.3 , pp. 185-206
    • Contrera, J.F.1    Matthews, E.J.2    Kruhlak, N.L.3    Benz, R.D.4
  • 3
    • 35349016814 scopus 로고    scopus 로고
    • Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development
    • DOI 10.1016/j.addr.2007.05.015, PII S0169409X07001731, Prediction of Therapeutic and Drug Delivery Outcomes Using Animal Models
    • Mahmood I. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development. Adv Drug Deliv Rev. 2007;59(11):1177-92. (Pubitemid 47615206)
    • (2007) Advanced Drug Delivery Reviews , vol.59 , Issue.11 , pp. 1177-1192
    • Mahmood, I.1
  • 4
    • 0030849120 scopus 로고    scopus 로고
    • An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience with Hoffmann La Roche
    • Reigner BG, Williams PE, Patel IH, Steimer JL, Peck C, van Brummelen P. An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffmann La Roche. Clin Pharmacokinet. 1997;33(2):142-52. (Pubitemid 27336953)
    • (1997) Clinical Pharmacokinetics , vol.33 , Issue.2 , pp. 142-152
    • Reigner, B.G.1    Williams, P.E.O.2    Patel, I.H.3    Steimer, J.-L.4    Peck, C.5    Van Brummelen, P.6
  • 5
    • 0035723305 scopus 로고    scopus 로고
    • Estimating the starting dose for entry into humans: Principles and practice
    • DOI 10.1007/s00228-001-0405-6
    • Reigner BG, Blesch KS. Estimating the starting dose for entry into humans: principles and practice. Eur J Clin Pharmacol. 2002;57(12):835-45. (Pubitemid 34185552)
    • (2002) European Journal of Clinical Pharmacology , vol.57 , Issue.12 , pp. 835-845
    • Reigner, B.G.1    Blesch, K.2
  • 6
    • 33344457255 scopus 로고    scopus 로고
    • A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry
    • DOI 10.1002/jps.20481
    • Tang H, Mayersohn M. A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry. J Pharm Sci. 2006;95(8):1783-99. (Pubitemid 44229585)
    • (2006) Journal of Pharmaceutical Sciences , vol.95 , Issue.8 , pp. 1783-1799
    • Tang, H.1    Mayersohn, M.2
  • 7
    • 0031690244 scopus 로고    scopus 로고
    • Response to the comments on the commentary 'Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: A critical view' [1]
    • DOI 10.1002/(SICI)1099-081X(199810)19:7<483::AID-BDD140>3.0.CO;2-Y
    • Mahmood I. Response to the comments on the commentary 'Prediction of absolute bioavailability for drugs using oral and renal clearance following a single oral dose: a critical view'. Biopharm Drug Dispos. 1998;19(7):483-4. (Pubitemid 28474566)
    • (1998) Biopharmaceutics and Drug Disposition , vol.19 , Issue.7 , pp. 483-484
    • Mahmood, I.1
  • 8
    • 0030918716 scopus 로고    scopus 로고
    • Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs
    • DOI 10.1021/js960440h
    • Lave T, Dupin S, Schmitt C, Chou RC, Jaeck D, Coassolo P. Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. J Pharm Sci. 1997;86(5):584-90. (Pubitemid 27203406)
    • (1997) Journal of Pharmaceutical Sciences , vol.86 , Issue.5 , pp. 584-590
    • Lave, Th.1    Dupin, S.2    Schmitt, C.3    Chou, R.C.4    Jaeck, D.5    Coassolo, Ph.6
  • 9
    • 51849087364 scopus 로고    scopus 로고
    • Estimation of human drug clearance using multiexponential techniques
    • Goteti K, Brassil PJ, Good SS, Garner CE. Estimation of human drug clearance using multiexponential techniques. J Clin Pharmacol. 2008;48(10):1226-36.
    • (2008) J Clin Pharmacol. , vol.48 , Issue.10 , pp. 1226-1236
    • Goteti, K.1    Brassil, P.J.2    Good, S.S.3    Garner, C.E.4
  • 10
    • 23944515735 scopus 로고    scopus 로고
    • A novel model for prediction of human drug clearance by allometric scaling
    • DOI 10.1124/dmd.105.004143
    • Tang H, Mayersohn M. A novel model for prediction of human drug clearance by allometric scaling. Drug Metab Dispos. 2005;33(9):1297-303. (Pubitemid 41196972)
    • (2005) Drug Metabolism and Disposition , vol.33 , Issue.9 , pp. 1297-1303
    • Tang, H.1    Mayersohn, M.2
  • 11
    • 34748919740 scopus 로고    scopus 로고
    • Interspecies prediction of human drug clearance based on scaling data from one or two animal species
    • DOI 10.1124/dmd.107.016188
    • Tang H, Hussain A, Leal M, Mayersohn M, Fluhler E. Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Drug Metab Dispos. 2007;35(10):1886-93. (Pubitemid 47481583)
    • (2007) Drug Metabolism and Disposition , vol.35 , Issue.10 , pp. 1886-1893
    • Tang, H.1    Hussain, A.2    Leal, M.3    Mayersohn, M.4    Fluhler, E.5
  • 13
    • 17644381224 scopus 로고    scopus 로고
    • Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches
    • DOI 10.1007/s11095-004-9015-1
    • Ito K, Houston JB. Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches. Pharm Res. 2005;22(1):103-12. (Pubitemid 40558152)
    • (2005) Pharmaceutical Research , vol.22 , Issue.1 , pp. 103-112
    • Ito, K.1    Houston, J.B.2
  • 14
    • 0032921527 scopus 로고    scopus 로고
    • Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro in vivo correlations
    • Lave T, Coassolo P, Reigner B. Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations. Clin Pharmacokinet. 1999;36 (3):211-31. (Pubitemid 29178759)
    • (1999) Clinical Pharmacokinetics , vol.36 , Issue.3 , pp. 211-231
    • Lave, T.1    Coassolo, P.2    Reigner, B.3
  • 15
    • 65449166750 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics from preclinical information: Comparative accuracy of quantitative prediction approaches
    • Hosea NA, Collard WT, Cole S, Maurer TS, Fang RX, Jones H, et al. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches. J Clin Pharmacol. 2009;49(5):513-33.
    • (2009) J Clin Pharmacol. , vol.49 , Issue.5 , pp. 513-533
    • Hosea, N.A.1    Collard, W.T.2    Cole, S.3    Maurer, T.S.4    Fang, R.X.5    Jones, H.6
  • 16
    • 35648945837 scopus 로고    scopus 로고
    • On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development
    • DOI 10.1080/00498250701648008, PII 783595319, Modelling and Simulation Approaches to in vitro-in vivo, Extrapolation of ADME Properties in Drug Development, Editor: Gordon Gibson, Guest Editor: Amin Rostami-Hodjegan
    • Lowe PJ, Hijazi Y, Luttringer O, Yin H, Sarangapani R, Howard D. On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development. Xenobiotica. 2007;37(10-11):1331-54. (Pubitemid 350035529)
    • (2007) Xenobiotica , vol.37 , Issue.10-11 , pp. 1331-1354
    • Lowe, P.J.1    Hijazi, Y.2    Luttringer, O.3    Yin, H.4    Sarangapani, R.5    Howard, D.6
  • 17
    • 34548393250 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics - Evaluation of methods for prediction of volume of distribution
    • DOI 10.1211/jpp.59.9.0001
    • Fagerholm U. Prediction of human pharmacokinetics-evaluation of methods for prediction of volume of distribution. J Pharm Pharmacol. 2007;59(9):1181-90. (Pubitemid 47359896)
    • (2007) Journal of Pharmacy and Pharmacology , vol.59 , Issue.9 , pp. 1181-1190
    • Fagerholm, U.1
  • 18
    • 34447312263 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics - Evaluation of methods for prediction of hepatic metabolic clearance
    • DOI 10.1211/jpp.59.6.0007
    • Fagerholm U. Prediction of human pharmacokinetics-evaluation of methods for prediction of hepatic metabolic clearance. J Pharm Pharmacol. 2007;59(6):803-28. (Pubitemid 47051093)
    • (2007) Journal of Pharmacy and Pharmacology , vol.59 , Issue.6 , pp. 803-828
    • Fagerholm, U.1
  • 19
    • 42549095582 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics - Biliary and intestinal clearance and enterohepatic circulation
    • DOI 10.1211/jpp.60.5.0001
    • Fagerholm U. Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation. J Pharm Pharmacol. 2008;60(5):535-42. (Pubitemid 351589043)
    • (2008) Journal of Pharmacy and Pharmacology , vol.60 , Issue.5 , pp. 535-542
    • Fagerholm, U.1
  • 20
    • 35848946788 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics - Renal metabolic and excretion clearance
    • DOI 10.1211/jpp.59.11.0002
    • Fagerholm U. Prediction of human pharmacokinetics-renal metabolic and excretion clearance. J Pharm Pharmacol. 2007;59 (11):1463-71. (Pubitemid 350057448)
    • (2007) Journal of Pharmacy and Pharmacology , vol.59 , Issue.11 , pp. 1463-1471
    • Fagerholm, U.1
  • 21
    • 33745798151 scopus 로고    scopus 로고
    • Methods to evaluate biliary excretion of drugs in humans: An updated review
    • DOI 10.1021/mp060011k
    • Ghibellini G, Leslie EM, Brouwer KL. Methods to evaluate biliary excretion of drugs in humans: an updated review. Mol Pharm. 2006;3(3):198-211. (Pubitemid 44021428)
    • (2006) Molecular Pharmaceutics , vol.3 , Issue.3 , pp. 198-211
    • Ghibellini, G.1    Leslie, E.M.2    Brouwer, K.L.R.3
  • 22
    • 0346992330 scopus 로고    scopus 로고
    • Progress towards prediction of human pharmacokinetic parameters from in vitro technologies
    • DOI 10.1081/DMR-120026870
    • Houston JB, Galetin A. Progress towards prediction of human pharmacokinetic parameters from in vitro technologies. Drug Metab Rev. 2003;35(4):393-415. (Pubitemid 38018114)
    • (2003) Drug Metabolism Reviews , vol.35 , Issue.4 , pp. 393-415
    • Houston, J.B.1    Galetin, A.2
  • 23
    • 68249152290 scopus 로고    scopus 로고
    • Prediction of hepatic clearance in human from in vitro data for successful drug development
    • Chiba M, Ishii Y, Sugiyama Y. Prediction of hepatic clearance in human from in vitro data for successful drug development. AAPS J. 2009;11(2):262-76.
    • (2009) AAPS J. , vol.11 , Issue.2 , pp. 262-276
    • Chiba, M.1    Ishii, Y.2    Sugiyama, Y.3
  • 24
    • 70350348642 scopus 로고    scopus 로고
    • To scale or not to scale: The principles of dose extrapolation
    • Sharma V, McNeill JH. To scale or not to scale: the principles of dose extrapolation. Br J Pharmacol. 2009;157(6):907-21.
    • (2009) Br J Pharmacol. , vol.157 , Issue.6 , pp. 907-921
    • Sharma, V.1    McNeill, J.H.2
  • 26
    • 0037974213 scopus 로고    scopus 로고
    • Selection of the first-time dose in humans: Comparison of different approaches based on interspecies scaling of clearance
    • Mahmood I, Green MD, Fisher JE. Selection of the first-time dose in humans: comparison of different approaches based on interspecies scaling of clearance. J Clin Pharmacol. 2003;43 (7):692-7. (Pubitemid 36759146)
    • (2003) Journal of Clinical Pharmacology , vol.43 , Issue.7 , pp. 692-697
    • Mahmood, I.1    Green, M.D.2    Fisher, J.E.3
  • 28
    • 61349174522 scopus 로고    scopus 로고
    • Use of pharmacokinetic/pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics
    • Agoram BM. Use of pharmacokinetic/pharmacodynamic modelling for starting dose selection in first-in-human trials of high-risk biologics. Br J Clin Pharmacol. 2009;67(2):153-60.
    • (2009) Br J Clin Pharmacol. , vol.67 , Issue.2 , pp. 153-160
    • Agoram, B.M.1
  • 29
    • 73349092713 scopus 로고    scopus 로고
    • Practical anticipation of human efficacious doses and pharmacokinetics using in vitro and preclinical in vivo data
    • Heimbach T, Lakshminarayana SB, Hu W, He H. Practical anticipation of human efficacious doses and pharmacokinetics using in vitro and preclinical in vivo data. AAPS J. 2009;11 (3):602-14.
    • (2009) AAPS J. , vol.11 , Issue.3 , pp. 602-614
    • Heimbach, T.1    Lakshminarayana, S.B.2    Hu, W.3    He, H.4
  • 31
    • 0025804183 scopus 로고
    • Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
    • Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991;175(3):880-5.
    • (1991) Biochem Biophys Res Commun. , vol.175 , Issue.3 , pp. 880-885
    • Artursson, P.1    Karlsson, J.2
  • 33
    • 60349087476 scopus 로고    scopus 로고
    • Safety assessment and dose selection for first-in-human clinical trials with immunomodulatory monoclonal antibodies
    • Muller PY, Brennan FR. Safety assessment and dose selection for first-in-human clinical trials with immunomodulatory monoclonal antibodies. Clin Pharmacol Ther. 2009;85(3):247-58.
    • (2009) Clin Pharmacol Ther. , vol.85 , Issue.3 , pp. 247-258
    • Muller, P.Y.1    Brennan, F.R.2
  • 34
    • 40549119872 scopus 로고    scopus 로고
    • The role of permeability in drug ADME/PK, interactions and toxicity - Presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans
    • DOI 10.1007/s11095-007-9397-y
    • Fagerholm U. The role of permeability in drug ADME/PK, interactions and toxicity-presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans. Pharm Res. 2008;25(3):625-38. (Pubitemid 351357725)
    • (2008) Pharmaceutical Research , vol.25 , Issue.3 , pp. 625-638
    • Fagerholm, U.1
  • 36
    • 36349035496 scopus 로고    scopus 로고
    • 2) in assessing the accuracy of interspecies allometric predictions: Illumination or illusion?
    • DOI 10.1124/dmd.107.016444
    • Tang H, Mayersohn M. Utility of the coefficient of determination (r2) in assessing the accuracy of interspecies allometric predictions: illumination or illusion? Drug Metab Dispos. 2007;35 (12):2139-42. (Pubitemid 350146215)
    • (2007) Drug Metabolism and Disposition , vol.35 , Issue.12 , pp. 2139-2142
    • Tang, H.1    Mayersohn, M.2
  • 38
    • 0033731283 scopus 로고    scopus 로고
    • Interspecies scaling: Role of protein binding in the prediction of clearance from animals to humans
    • Mahmood I. Interspecies scaling: role of protein binding in the prediction of clearance from animals to humans. J Clin Pharmacol. 2000;40(12 Pt 2):1439-46.
    • (2000) J Clin Pharmacol. , vol.40 , Issue.12 PART 2 , pp. 1439-1446
    • Mahmood, I.1
  • 40
    • 33747154776 scopus 로고    scopus 로고
    • Prediction of human drug clearance from animal data: Application of the rule of exponents and 'fu Corrected Intercept Method' (FCIM)
    • DOI 10.1002/jps.20650
    • Mahmood I. Prediction of human drug clearance from animal data: application of the rule of exponents and 'fu Corrected Intercept Method' (FCIM). J Pharm Sci. 2006;95(8):1810-21. (Pubitemid 44229587)
    • (2006) Journal of Pharmaceutical Sciences , vol.95 , Issue.8 , pp. 1810-1821
    • Mahmood, I.1
  • 42
    • 4844222525 scopus 로고    scopus 로고
    • A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans
    • DOI 10.1002/jps.20169
    • Nagilla R, Ward KW. A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans. J Pharm Sci. 2004;93(10):2522-34. (Pubitemid 39319435)
    • (2004) Journal of Pharmaceutical Sciences , vol.93 , Issue.10 , pp. 2522-2534
    • Nagilla, R.1    Ward, K.W.2
  • 43
    • 0028342648 scopus 로고
    • Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
    • DOI 10.1016/0006-2952(94)90520-7
    • Houston JB. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol. 1994;47(9):1469-79. (Pubitemid 24167255)
    • (1994) Biochemical Pharmacology , vol.47 , Issue.9 , pp. 1469-1479
    • Houston, J.B.1
  • 44
    • 17744363706 scopus 로고    scopus 로고
    • Interspecies scaling of biliary excreted drugs: A comparison of several methods
    • DOI 10.1002/jps.20313
    • Mahmood I. Interspecies scaling of biliary excreted drugs: a comparison of several methods. J Pharm Sci. 2005;94(4):883-92. (Pubitemid 40577320)
    • (2005) Journal of Pharmaceutical Sciences , vol.94 , Issue.4 , pp. 883-892
    • Mahmood, I.1
  • 45
    • 0029912492 scopus 로고    scopus 로고
    • Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling
    • DOI 10.1023/A:1016037519116
    • Lave T, Coassolo P, Ubeaud G, Brandt R, Schmitt C, Dupin S, et al. Interspecies scaling of bosentan, a new endothelin receptor antagonist and integration of in vitro data into allometric scaling. Pharm Res. 1996;13(1):97-101. (Pubitemid 26076303)
    • (1996) Pharmaceutical Research , vol.13 , Issue.1 , pp. 97-101
    • Lave, T.1    Coassolo, P.2    Ubeaud, G.3    Brandt, R.4    Schmitt, C.5    Dupin, S.6    Jaeck, D.7    Chou, R.C.8
  • 46
    • 0035147471 scopus 로고    scopus 로고
    • The prediction of human clearance from hepatic microsomal metabolism data
    • Obach RS. The prediction of human clearance from hepatic microsomal metabolism data. Curr Opin Drug Discov Devel. 2001;4(1):36-44. (Pubitemid 32118457)
    • (2001) Current Opinion in Drug Discovery and Development , vol.4 , Issue.1 , pp. 36-44
    • Obach, R.S.1
  • 47
    • 0036320379 scopus 로고    scopus 로고
    • Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: An application of serum incubation method
    • DOI 10.1124/dmd.30.8.892
    • Shibata Y, Takahashi H, Chiba M, Ishii Y Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method. Drug Metab Dispos. 2002;30(8):892-6. (Pubitemid 34815418)
    • (2002) Drug Metabolism and Disposition , vol.30 , Issue.8 , pp. 892-896
    • Shibata, Y.1    Takahashi, H.2    Chiba, M.3    Ishii, Y.4
  • 48
    • 76649134798 scopus 로고    scopus 로고
    • Prediction of human drug clearance from two species: A comparison of several allometric methods
    • Goteti K, Garner CE, Mahmood I. Prediction of human drug clearance from two species: a comparison of several allometric methods. J Pharm Sci. 2010;99(3):1601-13.
    • (2010) J Pharm Sci. , vol.99 , Issue.3 , pp. 1601-1613
    • Goteti, K.1    Garner, C.E.2    Mahmood, I.3
  • 49
    • 2442691625 scopus 로고    scopus 로고
    • A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time
    • DOI 10.1124/dmd.32.6.612
    • Ward KW, Smith BR. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. Drug Metab Dispos. 2004;32(6):612-9. (Pubitemid 38668153)
    • (2004) Drug Metabolism and Disposition , vol.32 , Issue.6 , pp. 612-619
    • Ward, K.W.1    Smith, B.R.2
  • 50
    • 67650151791 scopus 로고    scopus 로고
    • Role of fixed coefficients and exponents in the prediction of human drug clearance: How accurate are the predictions from one or two species?
    • Mahmood I. Role of fixed coefficients and exponents in the prediction of human drug clearance: how accurate are the predictions from one or two species? J Pharm Sci. 2009;98 (7):2472-93.
    • (2009) J Pharm Sci. , vol.98 , Issue.7 , pp. 2472-2493
    • Mahmood, I.1
  • 51
    • 0030614844 scopus 로고    scopus 로고
    • Physicochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH
    • DOI 10.1021/js960085v
    • Charman WN, Porter CJ, Mithani S, Dressman JB. Physiochem-ical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci. 1997;86 (3):269-82. (Pubitemid 27113759)
    • (1997) Journal of Pharmaceutical Sciences , vol.86 , Issue.3 , pp. 269-282
    • Charman, W.N.1    Porter, C.J.H.2    Mithani, S.3    Dressman, J.B.4
  • 52
    • 33644978712 scopus 로고    scopus 로고
    • On the observed large interspecies overprediction of human clearance ("vertical allometry") of UCN-01: Further support for a proposed model based on plasma protein binding
    • Tang H, Mayersohn M. On the observed large interspecies overprediction of human clearance ("vertical allometry") of UCN-01: further support for a proposed model based on plasma protein binding. J Clin Pharmacol. 2006;46(4):398-400.
    • (2006) J Clin Pharmacol. , vol.46 , Issue.4 , pp. 398-400
    • Tang, H.1    Mayersohn, M.2
  • 53
    • 33644893086 scopus 로고    scopus 로고
    • Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance
    • Hakooz N, Ito K, Rawden H, Gill H, Lemmers L, Boobis AR, et al. Determination of a human hepatic microsomal scaling factor for predicting in vivo drug clearance. Pharm Res. 2006;23 (3):533-9.
    • (2006) Pharm Res. , vol.23 , Issue.3 , pp. 533-539
    • Hakooz, N.1    Ito, K.2    Rawden, H.3    Gill, H.4    Lemmers, L.5    Boobis, A.R.6
  • 54
    • 3543026365 scopus 로고    scopus 로고
    • Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes
    • DOI 10.1023/B:PHAM.0000026429.12114.7d
    • Ito K, Houston JB. Comparison of the use of liver models for predicting drug clearance using in vitro kinetic data from hepatic microsomes and isolated hepatocytes. Pharm Res. 2004;21 (5):785-92. (Pubitemid 39011301)
    • (2004) Pharmaceutical Research , vol.21 , Issue.5 , pp. 785-792
    • Ito, K.1    Houston, J.B.2
  • 55
    • 0142074692 scopus 로고    scopus 로고
    • Application of a convective-dispersion model to predict in vivo hepatic clearance from in vitro measurements utilizing cryopreserved human hepatocytes
    • DOI 10.2174/1389200033489334
    • Niro R, Byers JP, Fournier RL, Bachmann K. Application of a convective-dispersion model to predict in vivo hepatic clearance from in vitro measurements utilizing cryopreserved human hepatocytes. Curr Drug Metab. 2003;4(5):357-69. (Pubitemid 37279361)
    • (2003) Current Drug Metabolism , vol.4 , Issue.5 , pp. 357-369
    • Niro, R.1    Byers, J.P.2    Fournier, R.L.3    Bachmann, K.4
  • 56
    • 0029027857 scopus 로고
    • Prediction of in vivo disposition from in vitro systems: Clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data
    • Ashforth EI, Carlile DJ, Chenery R, Houston JB. Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data. J Pharmacol Exp Ther. 1995;274(2):761-6.
    • (1995) J Pharmacol Exp Ther. , vol.274 , Issue.2 , pp. 761-766
    • Ashforth, E.I.1    Carlile, D.J.2    Chenery, R.3    Houston, J.B.4
  • 57
    • 0036194124 scopus 로고    scopus 로고
    • In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance
    • DOI 10.1124/jpet.301.1.382
    • Soars MG, Burchell B, Riley RJ. In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance. J Pharmacol Exp Ther. 2002;301(1):382-90. (Pubitemid 34250317)
    • (2002) Journal of Pharmacology and Experimental Therapeutics , vol.301 , Issue.1 , pp. 382-390
    • Soars, M.G.1    Burchell, B.2    Riley, R.J.3
  • 58
    • 33846405266 scopus 로고    scopus 로고
    • Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance
    • DOI 10.1124/dmd.106.011569
    • Brown HS, Griffin M, Houston JB. Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance. Drug Metab Dispos. 2007;35(2):293-301. (Pubitemid 46148743)
    • (2007) Drug Metabolism and Disposition , vol.35 , Issue.2 , pp. 293-301
    • Brown, H.S.1    Griffin, M.2    Houston, J.B.3
  • 59
    • 2942585051 scopus 로고    scopus 로고
    • In vitro testing of drug absorption for drug 'developability' assessment: Forming an interface between in vitro preclinical data and clinical outcome
    • Sun D, Yu LX, Hussain MA, Wall DA, Smith RL, Amidon GL. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. Curr Opin Drug Discov Devel. 2004;7 (1):75-85. (Pubitemid 44111916)
    • (2004) Current Opinion in Drug Discovery and Development , vol.7 , Issue.1 , pp. 75-85
    • Sun, D.1    Yu, L.X.2    Hussain, M.A.3    Wall, D.A.4    Smith, R.L.5    Amidon, G.L.6
  • 60
    • 0034835463 scopus 로고    scopus 로고
    • Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans
    • Naritomi Y, Terashita S, Kimura S, Suzuki A, Kagayama A, Sugiyama Y Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug Metab Dispos. 2001;29(10):1316-24. (Pubitemid 32896581)
    • (2001) Drug Metabolism and Disposition , vol.29 , Issue.10 , pp. 1316-1324
    • Naritomi, Y.1    Terashita, S.2    Kimura, S.3    Suzuki, A.4    Kagayama, A.5    Sugiyama, Y.6
  • 61
    • 0037403950 scopus 로고    scopus 로고
    • Utility of hepatocytes in predicting drug metabolism: Comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro
    • DOI 10.1124/dmd.31.5.580
    • Naritomi Y, Terashita S, Kagayama A, Sugiyama Y Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro. Drug Metab Dispos. 2003;31(5):580-8. (Pubitemid 36444167)
    • (2003) Drug Metabolism and Disposition , vol.31 , Issue.5 , pp. 580-588
    • Naritomi, Y.1    Terashita, S.2    Kagayama, A.3    Sugiyama, Y.4
  • 62
    • 0030911863 scopus 로고    scopus 로고
    • The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans
    • DOI 10.1023/A:1012036324237
    • Lave T, Dupin S, Schmitt C, Valles B, Ubeaud G, Chou RC, et al. The use of human hepatocytes to select compounds based on their expected hepatic extraction ratios in humans. Pharm Res. 1997;14(2):152-5. (Pubitemid 27146356)
    • (1997) Pharmaceutical Research , vol.14 , Issue.2 , pp. 152-155
    • Lave, Th.1    Dupin, S.2    Schmitt, C.3    Valles, B.4    Ubeaud, G.5    Chou, R.C.6    Jaeck, D.7    Coassolo, Ph.8
  • 63
    • 0034897160 scopus 로고    scopus 로고
    • Prediction of hepatic metabolic clearance comparison and assessment of prediction models
    • Zuegge J, Schneider G, Coassolo P, Lave T. Prediction of hepatic metabolic clearance: comparison and assessment of prediction models. Clin Pharmacokinet. 2001;40(7):553-63. (Pubitemid 32738661)
    • (2001) Clinical Pharmacokinetics , vol.40 , Issue.7 , pp. 553-563
    • Zuegge, J.1    Schneider, G.2    Coassolo, P.3    Lave, T.4
  • 64
    • 35349020575 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics - Improving microsome-based predictions of hepatic metabolic clearance
    • DOI 10.1211/jpp.59.10.0014
    • Fagerholm U. Prediction of human pharmacokinetics-improving microsome-based predictions of hepatic metabolic clearance. J Pharm Pharmacol. 2007;59(10):1427-31. (Pubitemid 47606459)
    • (2007) Journal of Pharmacy and Pharmacology , vol.59 , Issue.10 , pp. 1427-1431
    • Fagerholm, U.1
  • 65
    • 0032733974 scopus 로고    scopus 로고
    • Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes
    • Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos. 1999;27(11):1350-9.
    • (1999) Drug Metab Dispos. , vol.27 , Issue.11 , pp. 1350-1359
    • Obach, R.S.1
  • 66
    • 53849115780 scopus 로고    scopus 로고
    • Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance
    • Stringer R, Nicklin PL, Houston JB. Reliability of human cryopreserved hepatocytes and liver microsomes as in vitro systems to predict metabolic clearance. Xenobiotica. 2008;38 (10):1313-29.
    • (2008) Xenobiotica. , vol.38 , Issue.10 , pp. 1313-1329
    • Stringer, R.1    Nicklin, P.L.2    Houston, J.B.3
  • 67
    • 33646488018 scopus 로고    scopus 로고
    • A streamlined method to predict hepatic clearance using human liver microsomes in the presence of human plasma
    • Skaggs SM, Foti RS, Fisher MB. A streamlined method to predict hepatic clearance using human liver microsomes in the presence of human plasma. J Pharmacol Toxicol Methods. 2006;53(3):284-90.
    • (2006) J Pharmacol Toxicol Methods. , vol.53 , Issue.3 , pp. 284-290
    • Skaggs, S.M.1    Foti, R.S.2    Fisher, M.B.3
  • 68
    • 66449122160 scopus 로고    scopus 로고
    • Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions
    • Stringer RA, Strain-Damerell C, Nicklin P, Houston JB. Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Drug Metab Dispos. 2009;37(5):1025-34.
    • (2009) Drug Metab Dispos. , vol.37 , Issue.5 , pp. 1025-1034
    • Stringer, R.A.1    Strain-Damerell, C.2    Nicklin, P.3    Houston, J.B.4
  • 69
    • 9444270510 scopus 로고    scopus 로고
    • Utility of recombinant enzyme kinetics in prediction of human clearance: Impact of variability, CYP3A5, and CYP2C19 on CYP3A4 probe substrates
    • DOI 10.1124/dmd.104.000844
    • Galetin A, Brown C, Hallifax D, Ito K, Houston JB. Utility of recombinant enzyme kinetics in prediction of human clearance: impact of variability, CYP3A5, and CYP2C19 on CYP3A4 probe substrates. Drug Metab Dispos. 2004;32(12):1411-20. (Pubitemid 39564561)
    • (2004) Drug Metabolism and Disposition , vol.32 , Issue.12 , pp. 1411-1420
    • Galetin, A.1    Brown, C.2    Hallifax, D.3    Ito, K.4    Houston, J.B.5
  • 70
    • 58149472377 scopus 로고    scopus 로고
    • Prediction of drug clearance by glucuronidation from in vitro data: Use of combined cytochrome P450 and UDP-glucuronosyl-transferase cofactors in alamethicin-activated human liver microsomes
    • Kilford PJ, Stringer R, Sohal B, Houston JB, Galetin A. Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyl-transferase cofactors in alamethicin-activated human liver microsomes. Drug Metab Dispos. 2009;37(1):82-9.
    • (2009) Drug Metab Dispos. , vol.37 , Issue.1 , pp. 82-89
    • Kilford, P.J.1    Stringer, R.2    Sohal, B.3    Houston, J.B.4    Galetin, A.5
  • 72
    • 0036892637 scopus 로고    scopus 로고
    • Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis
    • DOI 10.1002/jps.10242
    • Wajima T, Fukumura K, Yano Y, Oguma T. Prediction of human clearance from animal data and molecular structural parameters using multivariate regression analysis. J Pharm Sci. 2002;91 (12):2489-99. (Pubitemid 35379407)
    • (2002) Journal of Pharmaceutical Sciences , vol.91 , Issue.12 , pp. 2489-2499
    • Wajima, T.1    Fukumura, K.2    Yano, Y.3    Oguma, T.4
  • 73
    • 70349584738 scopus 로고    scopus 로고
    • Prediction of hepatic microsomal intrinsic clearance and human clearance values for drugs
    • Nikolic K, Agababa D. Prediction of hepatic microsomal intrinsic clearance and human clearance values for drugs. J Mol Graph Model. 2009;28(3):245-52.
    • (2009) J Mol Graph Model. , vol.28 , Issue.3 , pp. 245-252
    • Nikolic, K.1    Agababa, D.2
  • 74
    • 85047685271 scopus 로고    scopus 로고
    • Predictive models for oral drug absorption: From in silico methods to integrated dynamical models
    • DOI 10.1517/17425225.3.4.491
    • Dokoumetzidis A, Kalantzi L, Fotaki N. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models. Expert Opin Drug Metab Toxicol. 2007;3(4):491-505. (Pubitemid 351324959)
    • (2007) Expert Opinion on Drug Metabolism and Toxicology , vol.3 , Issue.4 , pp. 491-505
    • Dokoumetzidis, A.1    Kalantzi, L.2    Fotaki, N.3
  • 75
    • 46449114275 scopus 로고    scopus 로고
    • Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds
    • DOI 10.1124/dmd.108.020479
    • Obach RS, Lombardo F, Waters NJ. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug Metab Dispos. 2008;36(7):1385-405. (Pubitemid 351929323)
    • (2008) Drug Metabolism and Disposition , vol.36 , Issue.7 , pp. 1385-1405
    • Obach, R.S.1    Lombardo, F.2    Waters, N.J.3
  • 76
    • 67049114269 scopus 로고    scopus 로고
    • Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption
    • Badhan R, Penny J, Galetin A, Houston JB. Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption. J Pharm Sci. 2009;98(6):2180-97.
    • (2009) J Pharm Sci. , vol.98 , Issue.6 , pp. 2180-2197
    • Badhan, R.1    Penny, J.2    Galetin, A.3    Houston, J.B.4
  • 77
    • 65549146053 scopus 로고    scopus 로고
    • Understanding the effect of API properties on bioavailability through absorption modeling
    • Kesisoglou F, Wu Y. Understanding the effect of API properties on bioavailability through absorption modeling. AAPS J. 2008;10 (4):516-25.
    • (2008) AAPS J. , vol.10 , Issue.4 , pp. 516-525
    • Kesisoglou, F.1    Wu, Y.2
  • 78
    • 0030990079 scopus 로고    scopus 로고
    • In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - Fact or myth
    • DOI 10.1023/A:1012102522787
    • Yee S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharm Res. 1997;14(6):763-6. (Pubitemid 27281671)
    • (1997) Pharmaceutical Research , vol.14 , Issue.6 , pp. 763-766
    • Yee, S.1
  • 80
    • 0029058745 scopus 로고
    • IAM chromatography: An in vitro screen for predicting drug membrane permeability
    • Pidgeon C, Ong S, Liu H, Qiu X, Pidgeon M, Dantzig AH, et al. IAM chromatography: an in vitro screen for predicting drug membrane permeability. J Med Chem. 1995;38(4):590-4.
    • (1995) J Med Chem. , vol.38 , Issue.4 , pp. 590-594
    • Pidgeon, C.1    Ong, S.2    Liu, H.3    Qiu, X.4    Pidgeon, M.5    Dantzig, A.H.6
  • 81
    • 0032568397 scopus 로고    scopus 로고
    • Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes
    • DOI 10.1021/jm970530e
    • Kansy M, Senner F, Gubernator K. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J Med Chem. 1998;41(7):1007-10. (Pubitemid 28207375)
    • (1998) Journal of Medicinal Chemistry , vol.41 , Issue.7 , pp. 1007-1010
    • Kansy, M.1    Senner, F.2    Gubernator, K.3
  • 82
    • 0036238280 scopus 로고    scopus 로고
    • A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential
    • DOI 10.1016/S0223-5234(02)01360-0, PII S0223523402013600
    • Zhu C, Jiang L, Chen TM, Hwang KK. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur J Med Chem. 2002;37(5):399-407. (Pubitemid 34465549)
    • (2002) European Journal of Medicinal Chemistry , vol.37 , Issue.5 , pp. 399-407
    • Zhu, C.1    Jiang, L.2    Chen, T.-M.3    Hwang, K.-K.4
  • 83
    • 33847188146 scopus 로고    scopus 로고
    • Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs
    • Kotecha J, Shah S, Rathod I, Subbaiah G. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs. Int J Pharm. 2007;333(1-2):127-35.
    • (2007) Int J Pharm. , vol.333 , Issue.1-2 , pp. 127-135
    • Kotecha, J.1    Shah, S.2    Rathod, I.3    Subbaiah, G.4
  • 86
    • 0031024171 scopus 로고    scopus 로고
    • Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
    • DOI 10.1016/S0169-409X(96)00423-1, PII S0169409X96004231
    • Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1-3):3-25. (Pubitemid 27046991)
    • (1997) Advanced Drug Delivery Reviews , vol.23 , Issue.1-3 , pp. 3-25
    • Lipinski, C.A.1    Lombardo, F.2    Dominy, B.W.3    Feeney, P.J.4
  • 87
    • 0033840471 scopus 로고    scopus 로고
    • Predicting human oral bioavailability of a compound: Development of a novel quantitative structure-bioavailability relationship
    • DOI 10.1023/A:1007556711109
    • Andrews CW, Bennett L, Yu LX. Predicting human oral bioavailability of a compound: development of a novel quantitative structure-bioavailability relationship. Pharm Res. 2000;17 (6):639-44. (Pubitemid 30670626)
    • (2000) Pharmaceutical Research , vol.17 , Issue.6 , pp. 639-644
    • Andrews, C.W.1    Bennett, L.2    Yu, L.X.3
  • 88
    • 0034729673 scopus 로고    scopus 로고
    • QSAR model for drug human oral bioavailability
    • DOI 10.1021/jm0000564
    • Yoshida F, Topliss JG. QSAR model for drug human oral bioavailability. J Med Chem. 2000;43(13):2575-85. (Pubitemid 30437140)
    • (2000) Journal of Medicinal Chemistry , vol.43 , Issue.13 , pp. 2575-2585
    • Yoshida, F.1    Topliss, J.G.2
  • 89
    • 0014763674 scopus 로고
    • Interspecies correlation of plasma concentration history of methotrexate (NSC-740)
    • Dedrick R, Bischoff KB, Zaharko DS. Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother Rep. 1970;54(2):95-101.
    • (1970) Cancer Chemother Rep. , vol.54 , Issue.2 , pp. 95-101
    • Dedrick, R.1    Bischoff, K.B.2    Zaharko, D.S.3
  • 90
    • 0033026297 scopus 로고    scopus 로고
    • A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods
    • DOI 10.1002/(SICI)1099-081X(199904)20:3<137::AID-BDD165>3.0.CO;2-I
    • Mahmood I, Yuan R. A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods. Biopharm Drug Dispos. 1999;20(3):137-44. (Pubitemid 29137671)
    • (1999) Biopharmaceutics and Drug Disposition , vol.20 , Issue.3 , pp. 137-144
    • Mahmood, I.1    Yuan, R.2
  • 91
    • 3042648079 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles
    • DOI 10.1002/jps.20099
    • Wajima T, Yano Y, Fukumura K, Oguma T. Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles. J Pharm Sci. 2004;93(7):1890-900. (Pubitemid 38823714)
    • (2004) Journal of Pharmaceutical Sciences , vol.93 , Issue.7 , pp. 1890-1900
    • Wajima, T.1    Yano, Y.2    Fukumura, K.3    Oguma, T.4
  • 92
    • 58749116164 scopus 로고    scopus 로고
    • Prediction of human oral pharmacokinetics using nonclinical data: Examples involving four proprietary compounds
    • Fura A, Vyas V, Humphreys W, Chimalokonda A, Rodrigues D. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds. Biopharm Drug Dispos. 2008;29(8):455-68.
    • (2008) Biopharm Drug Dispos. , vol.29 , Issue.8 , pp. 455-468
    • Fura, A.1    Vyas, V.2    Humphreys, W.3    Chimalokonda, A.4    Rodrigues, D.5
  • 93
    • 70350521133 scopus 로고    scopus 로고
    • Prediction of phase i single-dose pharmacokinet-ics using recombinant cytochromes P450 and physiologically based modelling
    • Gibson CR, Bergman A, Lu P, Kesisoglou F, Denney WS, Mulrooney E. Prediction of phase I single-dose pharmacokinet-ics using recombinant cytochromes P450 and physiologically based modelling. Xenobiotica. 2009;39(9):637-48.
    • (2009) Xenobiotica. , vol.39 , Issue.9 , pp. 637-648
    • Gibson, C.R.1    Bergman, A.2    Lu, P.3    Kesisoglou, F.4    Denney, W.S.5    Mulrooney, E.6
  • 94
    • 77149177347 scopus 로고    scopus 로고
    • On setting the first dose in man: Quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models
    • Lowe PJ, Tannenbaum S, Wu K, Lloyd P, Sims J. On setting the first dose in man: quantitating biotherapeutic drug-target binding through pharmacokinetic and pharmacodynamic models. Basic Clin Pharmacol Toxicol. 2010;106(3):195-209.
    • (2010) Basic Clin Pharmacol Toxicol. , vol.106 , Issue.3 , pp. 195-209
    • Lowe, P.J.1    Tannenbaum, S.2    Wu, K.3    Lloyd, P.4    Sims, J.5
  • 95
    • 34748925493 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetics using physiologically based modeling: A retrospective analysis of 26 clinically tested drugs
    • DOI 10.1124/dmd.107.015644
    • De Buck SS, Sinha VK, Fenu LA, Nijsen MJ, Mackie CE, Gilissen RA. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs. Drug Metab Dispos. 2007;35(10):1766-80. (Pubitemid 47481568)
    • (2007) Drug Metabolism and Disposition , vol.35 , Issue.10 , pp. 1766-1780
    • De Buck, S.S.1    Sinha, V.K.2    Fenu, L.A.3    Nijsen, M.J.4    Mackie, C.E.5    Gilissen, R.A.H.J.6
  • 96
    • 33646124969 scopus 로고    scopus 로고
    • A novel strategy for physiologically based predictions of human pharmacokinetics
    • Jones HM, Parrott N, Jorga K, Lave T. A novel strategy for physiologically based predictions of human pharmacokinetics. Clin Pharmacokinet. 2006;45(5):511-42.
    • (2006) Clin Pharmacokinet. , vol.45 , Issue.5 , pp. 511-542
    • Jones, H.M.1    Parrott, N.2    Jorga, K.3    Lave, T.4
  • 97
    • 0033576604 scopus 로고    scopus 로고
    • Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques
    • DOI 10.1021/jm991030j
    • Schneider G, Coassolo P, Lave T. Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques. J Med Chem. 1999;42(25):5072-6. (Pubitemid 30020258)
    • (1999) Journal of Medicinal Chemistry , vol.42 , Issue.25 , pp. 5072-5076
    • Schneider, G.1    Coassolo, P.2    Lave, T.3
  • 98
    • 33646421123 scopus 로고    scopus 로고
    • Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase i and phase II biotransformations
    • Mohutsky MA, Chien JY, Ring BJ, Wrighton SA. Predictions of the in vivo clearance of drugs from rate of loss using human liver microsomes for phase I and phase II biotransformations. Pharm Res. 2006;23(4):654-62.
    • (2006) Pharm Res. , vol.23 , Issue.4 , pp. 654-662
    • Mohutsky, M.A.1    Chien, J.Y.2    Ring, B.J.3    Wrighton, S.A.4
  • 99
    • 43349093221 scopus 로고    scopus 로고
    • Projection of exposure and efficacious dose prior to first-in-human studies: How successful have we been?
    • DOI 10.1007/s11095-007-9411-4
    • Huang C, Zheng M, Yang Z, Rodrigues AD, Marathe P. Projection of exposure and efficacious dose prior to first-inhuman studies: how successful have we been? Pharm Res. 2008;25(4):713-26. (Pubitemid 351661834)
    • (2008) Pharmaceutical Research , vol.25 , Issue.4 , pp. 713-726
    • Huang, C.1    Zheng, M.2    Yang, Z.3    Rodrigues, A.D.4    Marathe, P.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.